ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Zoledronate Induced AKI with Nephrotic Range Proteinuria in a Transplant Kidney

S. Reddy, H. Khamash

Nephrology, Mayo Clinic, Phoenix, AZ

Meeting: 2020 American Transplant Congress

Abstract number: D-225

Keywords: Adverse effects, Drug interaction, Kidney transplantation, Renal injury

Session Information

Date: Saturday, May 30, 2020

Session Name: Poster Session D: Non-Organ Specific: Pharmacogenomics / Pharmacokinetics

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

Related Abstracts
  • Cyclo (his-pro) Protects Against Gentamicin Induced Cell Apoptosis And Cisplatin Induced Acute Kidney Injury Through Inhibiting P53 Mediated Apoptotic Pathway.
  • Cellular Sources of Cytokine Production during Cold Ischemia Induced AKI after Kidney Transplant

*Purpose: An unusual presentation of acute kidney injury with nephrotic range proteinuria following zoledronate in a normal functioning transplant kidney.

*Methods: 61-year-old lady with history of ESRD due to diabetic nephropathy status post kidney transplant 3 years ago with stable allograft function on immunosuppressant’s tacrolimus and mycophenolate mofetil, presented to the ER with frothy urine and elevated blood pressure of 1 day. History significant for receiving IV zoledronate therapy for osteoporosis one week ago. Her physical examination was unremarkable. Labs were remarkable for stage II nonoliguric AKI. Patient’s creatinine trended up to 2.57 from baseline 0.8. Estimated GFR was 19 from baseline 75. UA showed grade 1 proteinuria, protein to creatinine ratio 7.5. Monoclonal study and immunofixation with urine and protein electrophoresis was normal. Urine sodium of 86. HLA antibody and BK nephropathy negative. Tacrolimus level was 6.7. Kidney biopsy showed mild interstitial fibrosis and tubular atrophy. Electron microscopy showed mild podocyte foot process effacement with no evidence of transplant glomerulopathy. Immunofluorescence showed no immune complex deposition.

*Results: AKI due to zoledronate is typically seen 7-9 days after therapy; this patient’s clinical course corresponded to the infusion timeline accordingly. An evaluation of all the available data suggested zoledronate induced nephrotoxicity in our patient, she was monitored in the hospital till her creatinine started to trend down by day 3. Follow up in 1 week showed that her creatinine returned to baseline at 0.88, urine protein to creatinine ratio <0.21.

*Conclusions: Nephrotoxicity is a potential limiting factor to the use of intravenous bisphosphonates. Literature shows, the severity of renal toxicity ranges from transient elevations in serum creatinine to segmental glomerulosclerosis with signs of acute renal failure. Extensive protocol exists for intravenous bisphosphonate therapy, which includes measuring serum creatinine prior to infusion and adjusting the dose as per GFR and monitoring renal function after the treatment. Intermittent evaluation of proteinuria is also recommended at 3-6 month intervals. Zoledronate is not recommended for use in patients with a creatinine clearance < 30 mL/minute, and the dose should be adjusted for CrCl values 30-60. Acute kidney injury in a kidney with normal GFR is virtually unknown. Patients with transplant kidneys will need cautious use of medications like zoledronate irrespective of the GFR.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Reddy S, Khamash H. Zoledronate Induced AKI with Nephrotic Range Proteinuria in a Transplant Kidney [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/zoledronate-induced-aki-with-nephrotic-range-proteinuria-in-a-transplant-kidney/. Accessed January 27, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.